Exci308® Phototherapy Treatment Provides Hope for Those with Autoimmune Conditions

Introduction

Affecting more than 400,000 million people around the world, treating autoimmune skin conditions such as Vitiligo, Psoriasis, and Atopic Dermatitis continue to be a challenge within the medical community. With many medications often producing minimal or temporary relief, patients are longing for a long-lasting solution with immediate results. Often thought of as a secondary option, advancements in safety and efficacy are making phototherapy devices, specifically the Exci308 by Aerolase®, the top choice for medical specialists.

The Exci308, a new energy-based device, utilizes 308nm light to help heal skin that has been affected by autoimmune diseases. With this treatment, providers will not have to sacrifice clinical efficiency for simplicity of design. According to a study published in the Journal of Clinical and Aesthetic Dermatology, the excimer laser has been noted as being efficient in the treatment of vitiligo, as well as being effective in the treatment of SV when combined with a topical steroid or topical calcineurin inhibitor.

Dr. Thierry Passerson

Passerson explains, “Vitiligo is probably the best indication for excimer phototherapy devices”. He goes on to say that, “Alopecia areata is our second main indication…In the case of children, excimer phototherapy is also an excellent choice to avoid side effects of corticoid injections”.

Aerolase has developed the Exci308 to provide an affordable option to treat autoimmune conditions, as well as provide quicker treatment times. The handheld device is able to help address conditions like leukoderma, psoriasis, vitiligo, alopecia, and atopic dermatitis. Aerolase continues to lead the industry when it comes to providing innovative technology that is results-oriented.